163 related articles for article (PubMed ID: 20444047)
41. Pharmacokinetics and dosing regimen of aminosidine in the dog.
Belloli C; Crescenzo G; Carli S; Villa R; Sonzogni O; Carelli G; Ormas P
Vet Res Commun; 1996; 20(6):533-41. PubMed ID: 8950834
[TBL] [Abstract][Full Text] [Related]
42. Comparative pharmacokinetics of an injectable cephalexin suspension in beef cattle.
Waxman Dova S; Albarellos G; Kreil V; Montoya L; Ambros L; Hallu R; Rebuelto M
Res Vet Sci; 2008 Dec; 85(3):570-4. PubMed ID: 18433809
[TBL] [Abstract][Full Text] [Related]
43. Subcutaneous administration of ceftazidime at 20 and 40 mg/kg produces theoretically therapeutic plasma concentrations for at least 120 hours in red-eared sliders (Trachemys scripta elegans).
Hiebert K; Cox S; Hawkins S
Am J Vet Res; 2024 May; 85(5):. PubMed ID: 38412607
[TBL] [Abstract][Full Text] [Related]
44. Pharmacokinetics of erythromycin after the administration of intravenous and various oral dosage forms to dogs.
Albarellos GA; Kreil VE; Ambros LA; Waxman S; Montoya L; Tarragona L; Quaine PC; Hallu RE; Rebuelto M
J Vet Pharmacol Ther; 2008 Dec; 31(6):496-500. PubMed ID: 19000270
[TBL] [Abstract][Full Text] [Related]
45. Pharmacokinetics of azithromycin after intravenous and intramuscular administration to goats.
Cárceles CM; Font A; Espuny A; Fernández-Varón E; Serrano JM; Escudero E
J Vet Pharmacol Ther; 2005 Feb; 28(1):51-5. PubMed ID: 15720515
[TBL] [Abstract][Full Text] [Related]
46. Pharmacokinetics and behavioral effects of oxymorphone after intravenous and subcutaneous administration to healthy dogs.
KuKanich B; Schmidt BK; Krugner-Higby LA; Toerber S; Smith LJ
J Vet Pharmacol Ther; 2008 Dec; 31(6):580-3. PubMed ID: 19000282
[No Abstract] [Full Text] [Related]
47. Comparative pharmacokinetics of amikacin following a single intramuscular or subcutaneous administration in goats (Capra hircus).
Uppal RP; Verma SP; Verma V; Garg SK
Vet Res; 1997; 28(6):565-70. PubMed ID: 9428150
[TBL] [Abstract][Full Text] [Related]
48. Intravenous and intramuscular pharmacokinetics of a single-daily dose of disodium-fosfomycin in cattle, administered for 3 days.
Sumano LH; Ocampo CL; Gutierrez OL
J Vet Pharmacol Ther; 2007 Feb; 30(1):49-54. PubMed ID: 17217401
[TBL] [Abstract][Full Text] [Related]
49. Tissue disposition of azithromycin after intravenous and intramuscular administration to rabbits.
Cárceles CM; Fernández-Varón E; Marín P; Escudero E
Vet J; 2007 Jul; 174(1):154-9. PubMed ID: 16904354
[TBL] [Abstract][Full Text] [Related]
50. Pharmacokinetics of an ampicillin-sulbactam (2:1) combination after intravenous and intramuscular administration to chickens.
Fernández-Varón E; Escudero E; Marín P; Cárceles CM
Vet Res Commun; 2006 Apr; 30(3):285-91. PubMed ID: 16437304
[No Abstract] [Full Text] [Related]
51. Pharmacokinetics of ceftazidime in sheep and its penetration into tissue and peritoneal fluids.
Rule R; Rubio M; Perelli MC
Res Vet Sci; 1991 Nov; 51(3):233-8. PubMed ID: 1780573
[TBL] [Abstract][Full Text] [Related]
52. Pharmacokinetics of cephalexin in the horse after intravenous and intramuscular administration of two formulations.
Villa R; Belloli C; Cagnardi P; Sonzogni O; Bacchetta S; Carli S
Vet J; 2002 Jul; 164(1):74-6. PubMed ID: 12359489
[No Abstract] [Full Text] [Related]
53. Pharmacokinetic studies of ceftazidime in serum, bone, bile, tissue fluid and peritoneal fluid.
Wittmann DH; Schassan HH; Kohler F; Seibert W
J Antimicrob Chemother; 1981 Sep; 8 Suppl B():293-7. PubMed ID: 19803001
[TBL] [Abstract][Full Text] [Related]
54. Pharmacokinetics of cefepime administered by i.v. and i.m. routes to ewes.
Ismail M
J Vet Pharmacol Ther; 2005 Dec; 28(6):499-503. PubMed ID: 16343281
[TBL] [Abstract][Full Text] [Related]
55. Pharmacokinetic behavior and pharmacokinetic/pharmacodynamic indices of marbofloxacin after intravenous, subcutaneous, and intramuscular administrations in buffalo calves (<10 days old).
Lüders C; Baroni EE; Rubio S; De Lucas JJ; Díaz DC; San Andrés MI
J Vet Pharmacol Ther; 2012 Jun; 35(3):301-4. PubMed ID: 21812790
[No Abstract] [Full Text] [Related]
56. Serum pharmacokinetics and sputum penetration of amikacin 30 mg/kg once daily and of ceftazidime 200 mg/kg/day as a continuous infusion in cystic fibrosis patients.
Byl B; Baran D; Jacobs F; Herschuelz A; Thys JP
J Antimicrob Chemother; 2001 Aug; 48(2):325-7. PubMed ID: 11481316
[No Abstract] [Full Text] [Related]
57. Comparative pharmacokinetics of desfuroylceftiofur acetamide after intramuscular versus subcutaneous administration of ceftiofur crystalline free acid to adult horses.
Fultz L; Giguère S; Berghaus LJ; Davis JL
J Vet Pharmacol Ther; 2013 Jun; 36(3):309-12. PubMed ID: 23240662
[No Abstract] [Full Text] [Related]
58. Efficacy and safety of subcutaneous administration of ceftazidime as a salvage therapy in geriatrics: a case report.
Michelon H; Tardivel M; Dinh A; Alvarez JC; Salomon E; Le Quintrec JL; Hirt D; Davido B
Fundam Clin Pharmacol; 2020 Aug; 34(4):521-524. PubMed ID: 31709583
[TBL] [Abstract][Full Text] [Related]
59. Pharmacokinetics of ceftiofur after single intravenous and intramuscular administration in camels (Camelus dromedarius).
Goudah A
J Vet Pharmacol Ther; 2007 Aug; 30(4):371-4. PubMed ID: 17610412
[No Abstract] [Full Text] [Related]
60. Pharmacokinetics of florfenicol in the plasma of Japanese quail.
Koc F; Uney K; Ozturk M; Kadioglu Y; Atila A
N Z Vet J; 2009 Dec; 57(6):388-91. PubMed ID: 19966901
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
